MCID: PLX001
MIFTS: 39

Plexiform Schwannoma malady

Categories: Cancer diseases, Neuronal diseases

Aliases & Classifications for Plexiform Schwannoma

About this section

Aliases & Descriptions for Plexiform Schwannoma:

Name: Plexiform Schwannoma 10 12 65
Plexiform Neurilemmoma 10
 
Plexiform Neurinoma 10

Classifications:



External Ids:

Disease Ontology10 DOID:3206
NCIt42 C6969
UMLS65 C1370659

Summaries for Plexiform Schwannoma

About this section
MalaCards based summary: Plexiform Schwannoma, also known as plexiform neurilemmoma, is related to transitional meningioma and melanotic neurilemmoma. An important gene associated with Plexiform Schwannoma is NF2 (Neurofibromin 2 (Merlin)), and among its related pathways is Mesenchymal Stem Cell Differentiation Pathways and Lineage-specific Markers. Affiliated tissues include lung, small intestine and salivary gland, and related mouse phenotypes are respiratory system and digestive/alimentary.

Related Diseases for Plexiform Schwannoma

About this section

Diseases related to Plexiform Schwannoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 132)
idRelated DiseaseScoreTop Affiliating Genes
1transitional meningioma10.7DSP, NF2
2melanotic neurilemmoma10.7NF1, NF2
3adult fibrosarcoma10.6NF1, NF2
4cellular neurofibroma10.6NF1, NF2
5chest wall lymphoma10.6NF1, NF2
6pituitary stalk meningioma10.6MIB1, NF2
7nerve root neoplasm10.6DSP, KIT
8skull base meningioma10.6MIB1, NF2
9epilepsy, familial focal, with variable foci10.6NF1, NF2
10skin benign neoplasm10.5KIT, NGFR
11gangliocytoma10.5ENO2, KIT
12sublingual gland adenoid cystic carcinoma10.5KIT, NGFR
13large cell carcinoma with rhabdoid phenotype10.4ENO2, NF1
14bartholin's gland small cell carcinoma10.4ENO2, KIT
15follicular infundibulum tumor10.4B3GAT1, NF1
16childhood cerebellar neoplasm10.4GFAP, NF2
17myositis ossificans10.4B3GAT1, CDSN
18anaplastic ganglioglioma10.4GFAP, NF2
19seminal vesicle adenocarcinoma10.4ENO2, KIT
20pilomyxoid astrocytoma10.4GFAP, NF2
21diffuse pulmonary fibrosis10.4ENO2, KIT
22eye disease10.4GFAP, NF2
23myxopapillary ependymoma10.4GFAP, NF2
24penis non-invasive verrucous carcinoma10.4ENO2, MIB1
25papillary ependymoma10.4GFAP, NF2
26complement component 3 deficiency10.3GFAP, NF1
27decubitus ulcer10.3KIT, NF1, NF2
28alveoli adenoma10.3GFAP, MIB1
29spina bifida occulta10.3ENO2, KIT
30adult malignant schwannoma10.3GFAP, MIB1
31neurofibromatosis10.3
32pulmonary plasma cell granuloma10.3B3GAT1, ENO2
33posterior foramen magnum meningioma10.3B3GAT1, ENO2
34head and neck carcinoma10.2GFAP, KIT
35colon small cell carcinoma10.2GFAP, MIB1
36meninges hemangiopericytoma10.2ENO2, MIB1
37neurofibroma of gallbladder10.2CD34, DSP
38plexiform schwannoma10.2CD34, NF2
39spinal cord oligodendroglioma10.2GFAP, MIB1
40preretinal fibrosis10.2NF1, NF2
41fibrous meningioma10.2CD34, NF2
42corneal neovascularization10.2ENO2, NF1, NF2
43pyelonephritis10.2ENO2, NF1, NF2
44anus leiomyosarcoma10.2CD34, KIT
45syphilis10.2ENO2, GFAP
46submandibular gland cancer10.2CD34, KIT
47ovary rhabdomyosarcoma10.2CD34, KIT
48indolent systemic mastocytosis10.2CD34, KIT
49conventional angiosarcoma10.2CD34, KIT
50small intestinal sarcoma10.2CD34, KIT

Graphical network of the top 20 diseases related to Plexiform Schwannoma:



Diseases related to plexiform schwannoma

Symptoms for Plexiform Schwannoma

About this section

Drugs & Therapeutics for Plexiform Schwannoma

About this section

Drugs for Plexiform Schwannoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 11)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Doxorubicinapproved, investigationalPhase 2, Phase 3158223214-92-831703
Synonyms:
(1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside
(8S-cis)-10-((3-amino-2,3,6-Trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione
111266-55-8
14-Hydroxydaunomycin
14-Hydroxydaunorubicine
14-hydroxydaunomycin
14-hydroxydaunorubicine
23214-92-8
23257-17-2
24385-08-8
25311-50-6
25316-40-9
25316-40-9 (hydrochloride)
29042-30-6
AC1L1M5T
AC1Q29OJ
ADM
ADR
Adriablastin
Adriacin (hydrochloride salt)
Adriamycin
Adriamycin PFS
Adriamycin PFS (hydrochloride salt)
Adriamycin RDF
Adriamycin RDF (hydrochloride salt)
Adriamycin Semiquinone
Adriamycin semiquinone
Adriblas tina
Adriblastin
Adriblastina
Adriblastina (TN)
Adriblastina (hydrochloride salt)
Aerosolized Doxorubicin
BPBio1_000502
BRD-K92093830-003-04-3
BSPBio_000456
BSPBio_001031
C01661
C27H29NO11
CCRIS 739
CHEBI:28748
CHEMBL179
CID31703
Caelyx
Conjugate of doxorubicin with humanized monoclonal antibody LL1 against CD74
Conjugate of doxorubicin with monoclonal antibody P4/D10 against GP120
D03899
DB00997
DM2
DOX-SL
Doxil
Doxo
Doxorubicin
Doxorubicin (USAN/INN)
Doxorubicin HCl
 
Doxorubicin Hydrochloride
Doxorubicin [USAN:INN:BAN]
Doxorubicin citrate
Doxorubicin hydrochloride (hydrochloride salt)
Doxorubicin-P4/D10
Doxorubicin-P4/D10 conjugate
Doxorubicin-hLL1
Doxorubicin-hLL1 conjugate
Doxorubicina
Doxorubicina [INN-Spanish]
Doxorubicine
Doxorubicine [INN-French]
Doxorubicinum
Doxorubicinum [INN-Latin]
EINECS 245-495-6
FI 106
Farmablastina (hydrochloride salt)
HMS2089H06
HSDB 3070
Hydroxydaunomycin hydrochlor ide (hydrochloride salt)
Hydroxydaunomycin hydrochloride (hydrochloride salt)
Hydroxydaunorubicin
Hydroxydaunorubicin hydrochloride (hydrochloride salt)
JT9100000
LMPK13050001
LS-1029
LS-165655
MLS000759533
Myocet
NCI-C01514
NChemBio.2007.10-comp13
NDC 38242-874
NIOSH/JT9100000
NSC 123127
Prestwick0_000438
Prestwick1_000438
Prestwick2_000438
Prestwick3_000438
Probes1_000151
Probes2_000129
RDF Rubex
Resmycin
Rubex
Rubex (hydrochloride salt)
SMP1_000106
SPBio_002395
TLC D-99
ThermoDox
Triferric doxorubicin
UNII-80168379AG
adiblastine (hydrochloride salt)
adr iablatina (hydrochloride salt)
adriablastine (hydrochloride salt)
adriablatina (hydrochloride salt)
adriblatina (hydrochloride salt)
doxorubicin
nchembio809-comp5
2
IfosfamideapprovedPhase 2, Phase 33713778-73-23690
Synonyms:
(+-)-Ifosfamid
(+-)-Ifosphamide
(+-)-Tetrahydro-N,3-bis(2-chloroethyl)-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
(D,L)-Ifosfamide
(R,S)-Ifosphamide
(R,S)-N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide
1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide
2,3-(N,N(sup 1)-Bis(2-chloroethyl)diamido)-1,3,2-oxazaphosphoridinoxyd
2,3-N,N(sup 1)-Bis(2-chloroethyl)diamido-1,3,2-oxazaphosphoridinoxyd
2H-1,3,2-Oxazaphosphorin-2-amine, N,3-bis( 2-chloroethyl)tetrahydro-, 2-oxide
2H-1,3,2-Oxazaphosphorin-2-amine, N,3-bis(2-chloroethyl)tetrahydro-, 2-oxide
2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide
2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide (8CI)
2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide
3,} 2-oxazaphosphorine oxide
3-(2-Chloroethyl)-2-((2-chloroethyl)amino)perhydro-2H-1,3,2-oxazaphosphorine oxide
3-(2-Chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide
3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,3,2-oxazaphosphorine oxide
3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,3,2-oxazaphosphorineoxide
3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2- oxide
3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide
36341-88-5
3778-73-2
84711-20-6
A 4942
AB00513932
AC-2113
AC1L1GHW
ASTA Z 4942
Ambap3778-73-2
Asta Z 4942
BPBio1_000865
BRN 0611835
BSPBio_000785
C07047
CAS-3778-73-2
CCRIS 352
CHEBI:5864
CHEMBL1024
CID3690
Cyfos
D00343
D007069
DB01181
EINECS 223-237-3
HMS1570H07
HMS2090M12
HMS2093N07
HSDB 7023
Holoxan
Holoxan 1000
I-Phosphamide
I06-0494
IFEX (TN)
Ifex
Ifosfamid
Ifosfamida
Ifosfamida [INN-Spanish]
Ifosfamide
 
Ifosfamide (JAN/USP/INN)
Ifosfamide Sterile
Ifosfamide [USAN:INN:BAN:JAN]
Ifosfamidum
Ifosfamidum [INN-Latin]
Ifosphamide
Ifsofamide
Iphosphamid
Iphosphamid(e)
Iphosphamide
Iso Endoxan
Iso-Endoxan
Isoendoxan
Isofosfamide
Isophosphamide
Isosfamide
LS-102
LS-99799
MJF 9325
MJF-9325
MLS002154021
Mitoxana
Mitoxana, Ifex, Ifosfamide
MolPort-003-666-704
N,3-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide
N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
N,N-Bis(beta-chloroethyl)-amino-N',O-propylene-phosphoric acid ester diamide
N-(2-Chloraethyl)-N'-(2-chloraethyl)-N',O-propylen-phosphorsaureester-diamid
N-(2-Chloraethyl)-N'-(2-chloraethyl)-N',O-propylen-phosphorsaureester-diamid [German]
N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylen ephosphoric acid diamide
N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylene phosphoric acid ester diamide
N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylenephosphoric acid diamide
N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylenephosphoric acid ester diamide
N-(2-Chloroethyl)-N-(3-(2-chloroethyl)-2-oxido-1,3,2-oxazaphosphinan-2-yl)amine
NCGC00016639-01
NCGC00179435-01
NCI-C01638
NCI60_000233
NPFAPI-04
NSC 109,724
NSC 109724
NSC-109,724
NSC-109724
NSC109,724
NSC109724
Naxamide
Prestwick0_000833
Prestwick1_000833
Prestwick2_000833
Prestwick3_000833
S1302_Selleck
SMR001233348
SPBio_002706
STL058690
UNII-UM20QQM95Y
WLN: T6NPOTJ AM2G BO B2G
Z 4942
Z-4942
Z4942
ifosfamide
isosfamide
{3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,
3
MechlorethamineapprovedPhase 2, Phase 330951-75-24033
Synonyms:
.Beta.,.beta.'-Dichlorodiethyl-N-methylamine
1, 5-Dichloro-3-methyl-3-azapentane hydrochloride
126-85-2 (N-oxide)
2,2'-Dichloro-N-me
2,2'-Dichloro-N-methyldiethylamine
2,2'-Dichlorodiethyl-methylamine
2,2'-dichloro-N-methyldiethylamine
2-Chloro-N-(2-chloroethyl)-N-methylethanamine
302-70-5 (N-oxide, hydrochloride)
51-75-2
55-86-7 (HYDROCHLORIDE)
AC1L1H9H
Antimit
BRN 0605323
BSPBio_001947
Bis(2-chloroethyl)methylamine
Bis(beta-chloroethyl) methylamine
Bis(beta-chloroethyl)methylamine
C07115
C5H11Cl2N
CCRIS 447
CHEBI:28925
CHEMBL427
CID4033
Carolysine
Caryolysin
Caryolysine
Chloramine (the nitrogen mustard)
Chlorethazine
Chlormethine
Chlormethine (INN)
Chlormethine [INN:BAN]
Chlormethinum [INN-Latin]
Cloramin
Clormetina
Clormetina [INN-Spanish]
D07671
DB00888
Di(2-chloroethyl)methylamine
Dichlor amine
Dichloren
DivK1c_000759
EINECS 200-120-5
ENT-25294
Embechine
Embichin
HMS1920J15
HMS2091B04
HMS502F21
HN-2
HN2
HSDB 5083
I14-8708
IBS-L0033631
IDI1_000759
KBio1_000759
KBio2_001369
KBio2_003937
KBio2_006505
KBio3_001447
KBioGR_001448
 
KBioSS_001369
LS-7559
MBA
Me chloroethamine
Mebichloramine
Mechlorethamine
Mechlorethamine hydrochloride
Mechlorethanamine
Mechloroethamine
Mecloretamina
Mecloretamina [Italian]
Methylbis(2-chloroethyl)amine
Methylbis(beta-chloroethyl)amine
Methyldi(2-chloroethyl)amine
Mitoxine (*Hydrochloride*)
MolPort-001-785-592
Mustargen
Mustine
Mustine note
Mutagen
N,N-Bis(2-chloroethyl)-N-methylamine
N,N-Bis(2-chloroethyl)methylamine
N,N-Di(chloroethyl)methylamine
N-Lost
N-Methyl lost
N-Methyl-2,2'-dichlorodiethylamine
N-Methyl-bis(2-chloroethyl)amine
N-Methyl-bis(beta-chloroethyl)amine
N-Methyl-bis-chloraethylamin
N-Methyl-bis-chloraethylamin [German]
N-Methyl-lost
N-Methyl-lost [German]
N-methyl-bis(2-chloroethyl)amine
NCGC00091835-02
NCGC00091835-03
NCGC00091835-04
NCGC00091835-05
NCI60_041682
NINDS_000759
NSC762
Nitol (*Hydrochloride*)
Nitrogen mustard
Nitrogen mustard (HN-2)
Nitrogranulogen
SPBio_000496
SPECTRUM1500375
Spectrum2_000448
Spectrum3_000484
Spectrum4_000924
Spectrum5_001702
Spectrum_000889
Stickstofflost (*Hydrochloride*)
Stickstofflost (ebewe)
T 1024
T-1024
TL 146
UNII-50D9XSG0VR
Valchlor
beta,Beta'-dichlorodiethyl-N-methylamine
beta,beta'-Dichlorodiethyl-N-methylamine
mechlorethamine
thyldiethylamine
╬▓,╬▓'-dichlorodiethyl-N-methylamine
4
Cyclophosphamideapproved, investigationalPhase 2, Phase 3264350-18-0, 6055-19-22907
Synonyms:
(+-)-Cyclophosphamide
(-)-Cyclophosphamide
(RS)-Cyclophosphamide
1-(bis(2-chloroethyl)amino)-1-oxo-2-aza-5-oxaphosphoridine
1-Bis(2-chloroethyl)amino-1-oxo-2-aza-5-oxaphosphoridin
2-[Bis(2-chloroethylamino)]-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide
4-Hydroxy-cyclophosphan-mamophosphatide
50-18-0
60007-95-6
6055-19-2 (monohydrate)
75526-90-8
AC1L1EQQ
AI3-26198
ASTA
ASTA B518
Asta B 518
B 518
B-518
BRN 0011744
BSPBio_002099
Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester
C 0768
C07888
C7H15Cl2N2O2P
CB 4564
CB-4564
CCRIS 188
CHEBI:4027
CHEMBL32520
CHEMBL88
CID2907
CP
CPA
CTX
CY
Ciclofosfamida
Ciclofosfamida [INN-Spanish]
Ciclofosfamide
Ciclophosphamide
Ciclophosphamide [INN]
Clafen
Claphene
Cycloblastin
Cyclophosphamid
Cyclophosphamide
Cyclophosphamide (INN)
Cyclophosphamide (TN)
Cyclophosphamide (anhydrous form)
Cyclophosphamide (anhydrous)
Cyclophosphamide Monohydrate
Cyclophosphamide Sterile
Cyclophosphamide anhydrous
Cyclophosphamide, (+-)-Isomer
Cyclophosphamides
Cyclophosphamidum
Cyclophosphamidum [INN-Latin]
Cyclophosphan
Cyclophosphane
Cyclophosphanum
Cyclophosphoramide
Cyclostin
Cyklofosfamid
Cyklofosfamid [Czech]
Cytophosphan
Cytophosphane
Cytoxan
Cytoxan (TN)
Cytoxan Lyoph
D,L-Cyclophosphamide
D07760
DB00531
 
DivK1c_000246
EINECS 200-015-4
EU-0100238
Endoxan
Endoxan R
Endoxan-Asta
Endoxana
Endoxanal
Endoxane
Enduxan
Genoxal
HMS2090A12
HSDB 3047
Hexadrin
IDI1_000246
KBio1_000246
KBio2_001338
KBio2_003906
KBio2_006474
KBio3_001319
KBioGR_000888
KBioSS_001338
LS-1302
LS-99787
Ledoxina
Lopac-C-0768
Lopac0_000238
Lyophilized Cytoxan
Mitoxan
MolPort-001-783-420
N,N-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide
N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
NCGC00015209-01
NCGC00015209-03
NCGC00015209-06
NCGC00091741-02
NCGC00091741-03
NCI-C04900
NCI60_002097
NINDS_000246
NSC 26271
NSC-26271
NSC26271
NSC273033
NSC273034
Neosar
Occupation, cyclophosphamide exposure
Procytox
RCRA waste no. U058
Rcra Waste Number U058
Rcra waste number U058
Revimmune
S1217_Selleck
SK 20501
SPBio_001071
STK177249
STOCK2S-91217
Semdoxan
Sendoxan
Senduxan
Spectrum2_001146
Spectrum3_000370
Spectrum4_000304
Spectrum5_000795
Spectrum_000858
UNII-6UXW23996M
WLN: T6MPOTJ BO BN2G2G
Zyklophosphamid
Zyklophosphamid [German]
bis(2-Chloroethyl)phosphami de cyclic propanolamide
bis(2-Chloroethyl)phosphamide cyclic propanolamide ester
cyclophosphamide
5
DoxilApproved June 1999Phase 2, Phase 3158231703
Synonyms:
Dox-SL
Doxil
 
Evacet
LipoDox
Pegylated Liposomal Doxorubicin Hydrochloride
liposomal doxorubicin
6Anti-Bacterial AgentsPhase 2, Phase 39140
7Topoisomerase InhibitorsPhase 2, Phase 34081
8Isophosphamide mustardPhase 2, Phase 3371
9Antibiotics, AntitubercularPhase 2, Phase 35971
10Antineoplastic Agents, AlkylatingPhase 2, Phase 33406
11Alkylating AgentsPhase 2, Phase 33582

Interventional clinical trials:

idNameStatusNCT IDPhase
1Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Hydrochloride Before Surgery in Treating Patients With Newly Diagnosed Non-Rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by SurgeryRecruitingNCT02180867Phase 2, Phase 3
2Natural History Study of Patients With Neurofibromatosis Type IRecruitingNCT00924196
3Transformation of Plexiform Neurofibromas to Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1RecruitingNCT02211768Phase 0
4Whole Body Magnetic Resonance Imaging With Diffusion Weighted Imaging : Potential Role in NeurofibromatosisRecruitingNCT01777451

Search NIH Clinical Center for Plexiform Schwannoma

Genetic Tests for Plexiform Schwannoma

About this section

Anatomical Context for Plexiform Schwannoma

About this section

MalaCards organs/tissues related to Plexiform Schwannoma:

33
Lung, Small intestine, Salivary gland, Pituitary, Prostate, Bone, Liver

Animal Models for Plexiform Schwannoma or affiliated genes

About this section

MGI Mouse Phenotypes related to Plexiform Schwannoma:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053888.7ENO2, KIT, NF1, NF2, NGFR
2MP:00053818.1DSP, GFAP, KIT, MIB1, NF1, NGFR
3MP:00107717.8CD34, DSP, KIT, MIB1, NF1, NF2
4MP:00053867.5B3GAT1, ENO2, GFAP, KIT, NF1, NF2
5MP:00053827.5DSP, ENO2, KIT, MIB1, NF1, NF2
6MP:00053787.2DSP, ENO2, GFAP, KIT, MIB1, NF1
7MP:00036316.7B3GAT1, DSP, ENO2, GFAP, KIT, MIB1
8MP:00053846.6CD34, DSP, ENO2, GFAP, KIT, MIB1

Publications for Plexiform Schwannoma

About this section

Articles related to Plexiform Schwannoma:

(show top 50)    (show all 63)
idTitleAuthorsYear
1
Congenital cellular plexiform schwannoma mimicking a vascular lesion: Potential pitfalls in clinical and histopathological assessment. (26728820)
2016
2
Congenital cellular plexiform schwannoma mimicking a vascular lesion: Potential pitfalls in clinical and histopathological assessment. (26658391)
2015
3
Plexiform schwannoma involving the trachea and recurrent laryngeal nerve: a case report. (26366364)
2015
4
A rare case of plexiform schwannoma of the lower lip: Treatment and management. (26424990)
2015
5
Oral plexiform schwannoma withA unusual epithelial induction. (26268670)
2015
6
Case presentations and review of plexiform schwannoma in the foot. (24556484)
2014
7
Plexiform schwannoma arising from cauda equina. (25264320)
2014
8
Plexiform schwannoma of the rectum. (23363231)
2014
9
Unusual intramaxillary plexiform schwannoma. (22847037)
2013
10
Neuroimage: giant plexiform schwannoma of the penis. (23207604)
2013
11
Plexiform schwannoma of the clitoris in a young girl: a case report. (23947092)
2013
12
A rare case of life-threatening giant plexiform schwannoma. (22209242)
2012
13
Plexiform schwannoma of the duodenum accompanying pyloric stenosis: report of a case. (22965512)
2012
14
Multiple plexiform schwannoma of a finger. (22266205)
2012
15
Plexiform Schwannoma of the nasal tip: surgical approach. (22714859)
2012
16
Lobular breast carcinoma metastasis to a superficial plexiform schwannoma as the first evidence of an occult breast cancer. (22123192)
2011
17
Plexiform schwannoma of the foot: a review of the literature and case report. (20833568)
2011
18
Intraosseus plexiform schwannoma of the mandible: immunohistochemical differential diagnosis. (21119430)
2010
19
Plexiform schwannoma of the esophagus in a child with neurofibromatosis type 2. (19573680)
2009
20
Plexiform schwannoma of the posterior tibial nerve: a case report. (19918424)
2009
21
Plexiform schwannoma in schwannomatosis. (19884750)
2009
22
Plexiform schwannoma of the lip mucosa. (19415817)
2009
23
Isolated plexiform schwannoma of the hand. (21886708)
2008
24
Congenital plexiform schwannoma of the clitoris. (18382807)
2008
25
Cutaneous plexiform schwannoma of the finger not associated with neurofibromatosis. (18284268)
2008
26
Plexiform schwannoma of scalp: a case report with brief review of literature. (18306559)
2007
27
Plexiform schwannoma of the clitoris. (17614860)
2007
28
Epithelioid angiosarcoma arising in a deep-seated plexiform schwannoma: a case report and literature review. (17574948)
2007
29
Intra-extradural plexiform schwannoma of the cervical spine. (17906563)
2007
30
Plexiform schwannoma mimicking haemangioma: pitfalls in clinical diagnosis and histological interpretation. (17714565)
2007
31
Recurrent plexiform schwannoma in vestibular mucosa. (16681871)
2006
32
Contiguous conventional and plexiform schwannomas. Report of two cases. (16509508)
2006
33
Plexiform schwannoma of the ulnar nerve. (16019742)
2005
34
Multiple plexiform schwannoma of the hand and forearm: a long-term follow-up. (15950336)
2005
35
Deep-seated plexiform schwannoma: a pathologic study of 16 cases and comparative analysis with the superficial variety. (16006798)
2005
36
MR imaging features of a scalp plexiform schwannoma. (14970034)
2004
37
Plexiform schwannoma of the forearm. (14593503)
2003
38
Plexiform schwannoma. (12823295)
2003
39
Case report: plexiform schwannoma of the vulva. (11827426)
2001
40
Esophageal Plexiform Schwannoma. (11494017)
2000
41
Plexiform schwannoma of the foot. (10525885)
1999
42
Plexiform schwannoma of the cheek. (10696390)
1999
43
Phenotypic diversity of neurofibromatosis 2: association with plexiform schwannoma. (9568513)
1998
44
Plexiform schwannoma of the neck extending deeply to the mediastinum. (10095874)
1998
45
Giant plexiform schwannoma: a report of two cases with soft tissue and visceral involvement. (9388056)
1997
46
Plexiform schwannoma (neurilemmoma) associated with macrodactyly: a case report. (8842974)
1996
47
Plexiform schwannoma. Immunohistochemistry of Schwann cell markers, intermediate filaments and extracellular matrix components. (7508103)
1993
48
Plexiform schwannoma. (4075640)
1985
49
50

Variations for Plexiform Schwannoma

About this section

Expression for genes affiliated with Plexiform Schwannoma

About this section
Search GEO for disease gene expression data for Plexiform Schwannoma.

Pathways for genes affiliated with Plexiform Schwannoma

About this section

Pathways related to Plexiform Schwannoma according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
18.9CD34, KIT, NGFR

GO Terms for genes affiliated with Plexiform Schwannoma

About this section

Cellular components related to Plexiform Schwannoma according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1myelin sheathGO:00432099.3ENO2, GFAP

Biological processes related to Plexiform Schwannoma according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1negative regulation of cell-matrix adhesionGO:000195310.1NF1, NF2
2visual learningGO:00085429.8KIT, NF1
3single organismal cell-cell adhesionGO:00163378.7CD34, CDSN, DSP

Sources for Plexiform Schwannoma

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet